Tudor Investment Corp
CELU icon

Tudor Investment Corp’s Celularity CELU Stock Holding History

Tudor Investment Corp’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,479
Closed -$127K – 2437
2022
Q3 		$127K Sell
5,479
-1,600
-23% -$48.6K ﹤0.01% 2143
2022
Q2 		$241K Buy
+7,079
New +$575K 0.01% 1706

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Tudor Investment Corp's CELU Position: Q4 2022 in Review

Tudor Investment Corp sold out of Celularity (CELU) in Q4 2022, closing a stake of 5,479 shares — an estimated $127K sold.

Tudor Investment Corp first reported a position in CELU in Q2 2022 and held it in 2 quarters. The position peaked at $241K in Q2 2022. 73 funds tracked by Wall St. Rank hold CELU as of Q4 2022.

  • Tudor Investment Corp reported no remaining Celularity position as of Q4 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 5,479 Celularity shares in Q4 2022, an estimated $127K.
  • Tudor Investment Corp first reported a position in Celularity in Q2 2022 and held it in 2 quarters.
  • Tudor Investment Corp's Celularity position peaked at $241K in Q2 2022.
  • 73 funds tracked by Wall St. Rank held Celularity as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.